UCB Protocol HS0003: A Phase 3 Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa (BE HEARD I) (Clinical Trial Conducted in Phoenix, Arizona – 7th Street Location) | Learn More » | Request to Join This Study »
Incyte Protocol INCB 54707-204: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa (Clinical Trial Conducted in Phoenix, Arizona – 7th Street Location) | Learn More » | Request to Join This Study »
Active / Not Enrolling
Phoenix, Arizona Clinical Trials:
AbbVie Protocol M20-040: Evaluation of Upadacitinib in Adult Subjects with Hidradenitis Suppurativa. (Clinical Trial Conducted in Phoenix, Arizona) | Learn More » | No Longer Enrolling